1.

General techniques
Starter cultures of E. coli bbBeas+ expression strains were grown overnight at 37°C in LB medium (3 ml) with shaking at 200 rpm. Main stage cultures (200 ml, LB medium) were inoculated with 3 ml of the starter culture, grown at 37°C with shaking at 200 rpm to an OD 600 of 1.0, and transferred to 16°C for induction with IPTG (200 µM, final concentration). Incubation with shaking at 200 rpm was continued for 16 hr at 16°C. Chloramphenicol (40 mg/ml, final concentration) was supplemented to all cultures. The cells were collected by centrifugation, and resuspended in fresh LB medium (20 ml) supplemented with D-Hiv and L-Phe (each at 15-30 mM, final concentrations). The resultant biotransformation reactions were incubated with shaking at 200 rpm for 48 hr at 16°C. The expression level of BbBEAS was ~0.4 mg/mL.
Quantification of in vivo analogue-production was performed by LC-ESI-MS/MS using an Agilent 6410 Triple Quadrupole LC/MS system in the Multiple Reaction Monitoring (MRM) mode. A 12 µg/mL stock solution of beauvericin from Sigma-Aldrich (purity ≥97 % by HPLC) was prepared in 100 % MeOH and 2x stepwise dilutions were made with MeOH to obtain the desired concentrations for the calibration standards. The concentrations of the beauvericin calibration standards ranged from 0.0015 to 12 µg/mL. Three replicates of each standard were analyzed and calibration curves, constructed by linear regression analysis, were plotted as the average peak area versus beauvericin concentrations. Results for the calibration curve showed good linearity with R 2 = 0.98. Calibration curve equations were used to calculate the concentrations of beauvericin in the samples based on their peak areas. For the quantification of beauvericin analogues, cells were collected from the biocatalytic reactions by centrifugation at 4500 rpm at 4 °C for 15 minutes as described earlier. C-NMR spectra were recorded on a Bruker Avance 400 NMR-spectrometer. The following abbreviations were used to explain the multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; band, several overlapping signals; b, broad. Optical rotation was recorded on a p-2000 polarimeter from Jasco Labor-und Datentechnik GmbH (Groß-Umstadt, Germany). High-resolution mass-spectroscopy (HRMS) using ESI-and EI-techniques was performed on a LTQ Orbitrap XL apparatus by Thermo Scientific (Waltham, MA, USA).
Calibartion Curve of Beauvericin
2.
Synthesis of α α α α-D-hydroxy acids
The following compounds were synthesized according to published methods: 1-5, 7-9, 11, 13-33 [1] ; 10 [2] ; 6 [3] .
For the following substrates, synthesis followed the general procedures of Feifel et al. [3] and Müller et al. [1] Briefly, a solution of sodium nitrite (6.0 equiv) in H 2 O (1.35 mL/mM) was added slowly to a solution of α-D-amino acid (1.0 equiv) in 0.5 M H 2 SO 4 (2 mL/mM, 2.0 equiv) at 0°C. The reaction was stirred at 0°C for 3h and was then allowed to warm up to room temperature while stirring for 24h. The reaction mixture was extracted three times with diethyl ether (5mL/mM). The combined organic layers were washed with brine (5 mL/mM), dried over Na 2 SO 4 , filtered and concentrated to afford the product as the α-D-hydroxy carboxylic acid. Supplementary Fig. 1 . In vitro chemoenzymatic synthesis of beauvericin analogues. Line densitometric traces and X-ray photographic images of thin layer chromatographic plates for reactions with: A. Precursors 3, 13 and 14; and B. Precursors 3, 2, 10, and 12. Control reactions without hydroxycarboxylic acid (-) and without L-Phe but with precursor 3 (3-Phe) are also shown.
